Loading
AI Proteins designs small proteins as possible medicines and lists cancer research programmes that would carry radiation to a target.
AI Proteins develops de novo miniproteins, proteins designed from first principles. Its pipeline lists internal oncology programmes described as targeted radiotherapy, with undisclosed targets. The page also lists programmes outside oncology. The oncology entries do not establish clinical benefit, and no specific cancer indication or trial phase is inferred from the pipeline graphic.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/